PRX Research Site #825 — Mesquite, Texas

PRX Research Site #825 is a clinical research site located in Mesquite, Texas, United States 75149.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

PRX Research Site #825 has participated in 2 clinical trials.

Therapeutic areas: Agitation in Patients With Dementia of the Alzheimer's Type.

Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Mesquite

Browse all research sites in Texas · View every site in Mesquite

• SMS Clinical Research
• Southwest Rheumatology Research
• Southern Endocrinology Associates
• Research Site
• Novartis Investigative Site
• Texas Cancer Center of Mesquite
• Pfizer Investigational Site
• Novo Nordisk Investigational Site
• Investigational Site Number 840074
• GSK Investigational Site
• Southern Endocrinology Associates PA
• Southwest Rheumatology

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for PRX Research Site #825?

PRX Research Site #825 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has PRX Research Site #825 conducted?

PRX Research Site #825 has 2 clinical trials on record. Their work covers Agitation in Patients With Dementia of the Alzheimer's Type.

Is PRX Research Site #825 accredited by Crixeo Clinical Trials?

PRX Research Site #825 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about PRX Research Site #825?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.